2008, Number 4
Next >>
Rev Endocrinol Nutr 2008; 16 (4)
rhTSH: What do we have? What do we expect? and in whom is it really needed?
Hernández MAF, Hernández GI
Language: Spanish
References: 6
Page: 142-143
PDF size: 61.56 Kb.
Text Extraction
No abstract
REFERENCES
Sanchez R, Espinosa-de-los Monteros AL, Mendoza V et al. Adequate thyroid-stimulating levels after levothyroxin discontinuation in the follow-up of patients with well differentiated thyroid carcinoma. Arch Med Res 2002; 33: 478-481.
Kuijt WJ, Huang SA. Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. J Clin Endocrinol Metab 2005; 90: 6123-6125.
Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005; 90: 5047-57.
Zanotti-Fregonara, Khoury A, Duron F et al. Which thyroid cancer patients need periodic stimulation test? Eur J Med Mol Imaging 2007; 34: 541-546.
Haugen BR, Cooper DS, Emerson CH et al. Expanding indications for recombinant human TSH in thyroid cancer. Thyroid 2008;18: 687-694
Full text